Carolina B. Belli

Dr. Carolina B. Belli


Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 June 2011 in American Journal of Hematology
Verified
Journal Article
Closed access
PDF file
CBCarolina B. Belli
Carolina B. Belli
RBRaquel Bengió
Raquel Bengió
PAPedro Negri Aranguren
Pedro Negri Aranguren
FSFrancisco Sakamoto
Francisco Sakamoto
MFMaría G. Flores
María G. Flores
ILIrene Larripa
Irene Larripa

10 September 2015 in American Journal of Hematology
Verified
Journal Article
Closed access
PDF file
CBCarolina B. Belli
Carolina B. Belli
RPRonald Feitosa Pinheiro
Ronald Feitosa Pinheiro
YBYesica Bestach
Yesica Bestach
ILIrene B. Larripa
Irene B. Larripa
RTRoberta Sandra da Silva Tanizawa
Roberta Sandra da Silva Tanizawa
EVElvira Deolinda Rodrigues Pereira Velloso
Elvira Deolinda Rodrigues Pereira Velloso

1 December 2011 in Blood Cells, Molecules, and Diseases
Verified
Journal Article
Closed access
CBCarolina B. Belli
Carolina B. Belli
YBYesica Bestach
Yesica Bestach
YSYamila Sieza
Yamila Sieza
MGMarta Gelemur
Marta Gelemur
MGMario Giunta
Mario Giunta
ILIrene Larripa
Irene Larripa

9 March 2023 in Annals of Hematology
Verified
Journal Article
Closed access
PDF file
LFLuciana C Ferrari
Luciana C Ferrari
MRMaría M Rivas
María M Rivas
ANAlicia B Navickas
Alicia B Navickas
HDHernán Dick
Hernán Dick
MOMaría J Mela Osorio
María J Mela Osorio
O(On Behalf Of The Grupo Argentino de Leucemias Agudas (Gala) And Grupo Argentino de Tratamiento de Leucemias Agudas (Gatla)
On Behalf Of The Grupo Argentino de Leucemias Agudas (Gala) And Grupo Argentino de Tratamiento de Leucemias Agudas (Gatla)

26 July 2024 in Annals of Laboratory Medicine
Verified
Journal Article
Open access
PDF file
MLMarco Lincango
Marco Lincango
VAVerónica Andreoli
Verónica Andreoli
HRHernán García Rivello
Hernán García Rivello
ABAndrea Bender
Andrea Bender
ACAna I Catalán
Ana I Catalán
CBCarolina B. Belli
Carolina B. Belli
Marco Lincango, M.S., Verónica Andreoli, Ph.D., Hernán García Rivello, Ph.D., Andrea Bender, Biochem., Ana I Catalán, M.S., Marilina Rahhal, Biochem., Rocío Delamer, Biochem., Mariana Asinari, Biochem., Adrián Mosquera Orgueira, Ph.D., María Belén Castro, M.D., María José Mela Osorio, M.D., Alicia Navickas, M.D., Sofia Grille, Ph.D., Evangelina Agriello, Biochem., Jorge Arbelbide, M.D., Ana Lisa Basquiera, Ph.D., and Carolina B Belli, Ph.D.. Ann Lab Med -0001;0:. https://doi.org/10.3343/alm.2024.0089

6 January 2011 in Cytogenetic and Genome Research
Verified
Journal Article
Closed access
CBCarolina B. Belli
Carolina B. Belli
MAM.F. Alú
M.F. Alú
GAG. Alfonso
G. Alfonso
MBM. Bianchini
M. Bianchini
ILI. Larripa
I. Larripa
Chronic myeloid leukemia (CML) is a clonal malignant disorder of a pluripotent hematopoietic stem cell characterized by the presence of a Philadelphia (Ph) chromosome. Less than 10% of patients present variant Ph chromosomes involving 1 or more additional chromosomes, other than chromosomes 9 and 22, with uncertain prognosis. There are mainly 1- or 2-step mechanisms proposed to explain the genesis of variant Ph chromosomes depending on whether the involved chromosomes are simultaneously broken and rejoined or if a standard t(9;22) occurs first. By combined standard cytogenetic and FISH analysis we detected a novel variant Ph translocation among chromosomes 9, 11 and 22 in a patient with CML without progression to an accelerated phase of the disease after 7 years, with the derivative chromosome 9 also having an acquired pericentric inversion. This novel case illustrates the use of FISH in metaphase to confirm a new rearrangement not previously described in variant Ph formation and that the present karyotype could have originated by a 1-step mechanism with 4 simultaneous breakages without deletion of ABL1.